GIM
CSII

Granahan Investment Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Granahan Investment Management’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-362,330
Closed -$11.9M – 199
2021
Q3 		$11.9M Sell
362,330
-42,514
-11% -$1.59M 0.23% 101
2021
Q2 		$17.3M Sell
404,844
-66,421
-14% -$2.6M 0.32% 76
2021
Q1 		$18.1M Sell
471,265
-3,673
-0.8% -$156K 0.38% 60
2020
Q4 		$20.8M Sell
474,938
-86,671
-15% -$3.26M 0.47% 54
2020
Q3 		$22.1M Buy
561,609
+268,125
+91% +$8.66M 0.75% 37
2020
Q2 		$9.26M Buy
293,484
+2,228
+0.8% +$83.2K 0.33% 83
2020
Q1 		$10.3M Buy
291,256
+5,707
+2% +$241K 0.55% 47
2019
Q4 		$13.9M Sell
285,549
-1,178
-0.4% -$53.6K 0.64% 45
2019
Q3 		$13.6M Sell
286,727
-99,461
-26% -$4.67M 0.75% 36
2019
Q2 		$16.6M Sell
386,188
-50,951
-12% -$1.98M 0.82% 36
2019
Q1 		$16.9M Buy
437,139
+88,289
+25% +$2.99M 0.91% 36
2018
Q4 		$9.94M Sell
348,850
-8,241
-2% -$262K 0.7% 49
2018
Q3 		$14M Sell
357,091
-23,965
-6% -$886K 0.76% 43
2018
Q2 		$12.3M Buy
381,056
+92,042
+32% +$2.53M 0.74% 42
2018
Q1 		$6.34M Buy
289,014
+22,056
+8% +$530K 0.46% 78
2017
Q4 		$6.32M Sell
266,958
-39,100
-13% -$986K 0.5% 73
2017
Q3 		$8.62M Buy
306,058
+19,398
+7% +$590K 0.72% 43
2017
Q2 		$9.24M Sell
286,660
-74,435
-21% -$2.27M 0.85% 32
2017
Q1 		$10.2M Sell
361,095
-794,895
-69% -$21.1M 1.02% 28
2016
Q4 		$28M Buy
1,155,990
+26,100
+2% +$640K 0.96% 30
2016
Q3 		$26.8M Buy
1,129,890
+11,010
+1% +$241K 0.88% 30
2016
Q2 		$20.6M Buy
1,118,880
+128,275
+13% +$2M 0.75% 40
2016
Q1 		$10.3M Sell
990,605
-11,015
-1% -$112K 0.37% 94
2015
Q4 		$15.1M Sell
1,001,620
-247,680
-20% -$3.68M 0.52% 70
2015
Q3 		$19.8M Buy
1,249,300
+463,600
+59% +$11.7M 0.61% 52
2015
Q2 		$20.8M Buy
785,700
+136,200
+21% +$4.4M 0.59% 61
2015
Q1 		$25.4M Buy
649,500
+109,700
+20% +$3.78M 0.73% 46
2014
Q4 		$16.2M Hold
539,800
– – 0.47% 83
2014
Q3 		$12.8M Buy
539,800
+329,710
+157% +$9.38M 0.39% 93
2014
Q2 		$6.55M Buy
+210,090
New +$6.06M 0.19% 151

Other funds holding CSII

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Granahan Investment Management's CSII Position: Q4 2021 in Review

Granahan Investment Management sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2021, closing a stake of 362,330 shares — an estimated $11.9M sold.

Granahan Investment Management first reported a position in CSII in Q2 2014 and held it in 30 quarters. The position peaked at $28M in Q4 2016. 167 funds tracked by Wall St. Rank hold CSII as of Q4 2021.

  • Granahan Investment Management reported no remaining Cardiovascular Systems, Inc. position as of Q4 2021 after selling out during the quarter.
  • Granahan Investment Management sold 362,330 Cardiovascular Systems, Inc. shares in Q4 2021, an estimated $11.9M.
  • Granahan Investment Management first reported a position in Cardiovascular Systems, Inc. in Q2 2014 and held it in 30 quarters.
  • Granahan Investment Management's Cardiovascular Systems, Inc. position peaked at $28M in Q4 2016.
  • 167 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2021.

Based on Granahan Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.